Assessment of the N-oxidation of deprenyl, methamphetamine, and amphetamine enantiomers by chiral capillary electrophoresis: an in vitro metabolism study
- PMID: 15352021
- DOI: 10.1002/elps.200406023
Assessment of the N-oxidation of deprenyl, methamphetamine, and amphetamine enantiomers by chiral capillary electrophoresis: an in vitro metabolism study
Abstract
A chiral capillary electrophoresis method using hydroxypropyl-beta-cyclodextrin as chiral selector was developed and validated for the quantification of the N-oxygenated metabolites of deprenyl, methamphetamine, and amphetamine enantiomers, formed in vitro. The influence of various parameters (selector concentration, buffer pH, temperature, polymer additive, etc.) on the simultaneous separation of the optical isomers of the parent drugs and their metabolites has been evaluated. The buffer pH had the greatest impact on the separation selectivity of the N-oxygenated compounds. Linear calibration curves were obtained over the concentration range of 2.5-50 microM for the enantiomers of amphetamine-hydroxylamine, methamphetamine-hydroxylamine, and deprenyl-N-oxide. The inter- and intra-assay precision and accuracy varied by less than 15% for all analytes at concentrations of 5, 10, and 30 microM, and less than 20% at the lower limit of quantitation (2.5 microM). The sample extraction recovery ranged between 109 and 129% at the three concentration levels. The drug enantiomers were incubated with recombinant human flavin-containing monooxygenase enzymes (FMO3 and FMO1), and human liver microsomes, respectively. The enantioselectivity of the substrate preference, as well as the stereoselective formation of the new chiral center upon the oxidation of the prochiral tertiary nitrogen of deprenyl were assessed. FMO1, the extrahepatic form of the enzyme in man, was shown to be more active in the N-oxygenation of both deprenyl and methamphetamine isomers than FMO3. Deprenyl enantiomers and S-methamphetamine were substrates of human recombinant FMO3. Conversion of amphetamine to its hydroxylamine derivative could not be observed on incubation with either FMO1 or FMO3. Formation of the new chiral center on the nitrogen, during N-oxidation of the tertiary amine deprenyl, was found stereoselective. The two FMO isoforms have shown opposite preference in the formation of this chiral center. Methamphetamine-hydroxylamine formed from methamphetamine was further transformed by FMO, amphetamine-hydroxylamine was identified as the product of a demethylation reaction.
Similar articles
-
N-oxygenation of amphetamine and methamphetamine by the human flavin-containing monooxygenase (form 3): role in bioactivation and detoxication.J Pharmacol Exp Ther. 1999 Mar;288(3):1251-60. J Pharmacol Exp Ther. 1999. PMID: 10027866
-
Chiral characterization of deprenyl-N-oxide and other deprenyl metabolites by capillary electrophoresis using a dual cyclodextrin system in rat urine.Electrophoresis. 2003 Aug;24(15):2665-73. doi: 10.1002/elps.200305468. Electrophoresis. 2003. PMID: 12900880
-
Stereoselective screening for and confirmation of urinary enantiomers of amphetamine, methamphetamine, designer drugs, methadone and selected metabolites by capillary electrophoresis.Electrophoresis. 1999 Sep;20(13):2726-38. doi: 10.1002/(SICI)1522-2683(19990901)20:13<2726::AID-ELPS2726>3.0.CO;2-6. Electrophoresis. 1999. PMID: 10532341
-
Role of hepatic flavin-containing monooxygenase 3 in drug and chemical metabolism in adult humans.Chem Biol Interact. 1995 Apr 28;96(1):33-46. doi: 10.1016/0009-2797(94)03581-r. Chem Biol Interact. 1995. PMID: 7720103 Review.
-
Precursor medications as a source of methamphetamine and/or amphetamine positive drug testing results.J Occup Environ Med. 2002 May;44(5):435-50. doi: 10.1097/00043764-200205000-00012. J Occup Environ Med. 2002. PMID: 12024689 Review.
Cited by
-
Cytoprotective effect of (-)-deprenyl, (-)desmethyl-deprenyl and (-)deprenyl-N-oxide on glutathione depleted A-2058 melanoma cells.J Neural Transm (Vienna). 2010 Jun;117(6):695-8. doi: 10.1007/s00702-010-0413-8. Epub 2010 May 9. J Neural Transm (Vienna). 2010. PMID: 20454984
-
Roles of selected non-P450 human oxidoreductase enzymes in protective and toxic effects of chemicals: review and compilation of reactions.Arch Toxicol. 2022 Aug;96(8):2145-2246. doi: 10.1007/s00204-022-03304-3. Epub 2022 Jun 1. Arch Toxicol. 2022. PMID: 35648190 Free PMC article. Review.
-
R-deprenyl: pharmacological spectrum of its activity.Neurochem Res. 2010 Dec;35(12):1922-32. doi: 10.1007/s11064-010-0238-8. Epub 2010 Aug 20. Neurochem Res. 2010. PMID: 20725780
-
Formation of potentially toxic metabolites of drugs in reactions catalyzed by human drug-metabolizing enzymes.Arch Toxicol. 2024 Jun;98(6):1581-1628. doi: 10.1007/s00204-024-03710-9. Epub 2024 Mar 23. Arch Toxicol. 2024. PMID: 38520539 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical